Erasca Inc (ERAS)

01:13 AM

Erasca, Inc. (NASDAQ:ERAS) Receives $4.83 Consensus Price Target from Brokerages - Defense World

01:13 AM

Apr 03, 2025

Teacher Retirement System of Texas Buys 12,345 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 03, 2025

Apr 02, 2025

Erasca Insiders Lose Out As Stock Sinks To US$1.21 - simplywall.st

Apr 02, 2025

Apr 01, 2025

Erasca stock hits 52-week low at $1.23 amid market challenges - Investing.com India

Apr 01, 2025

Mar 30, 2025

Erasca (NASDAQ:ERAS) Coverage Initiated by Analysts at Raymond James - MarketBeat

Mar 30, 2025

Mar 30, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Bought by Swiss National Bank - Defense World

Mar 30, 2025

Mar 27, 2025

Erasca (NASDAQ:ERAS) Now Covered by Analysts at Raymond James - Defense World

Mar 27, 2025

Mar 26, 2025

Raymond James sets $5 target for Erasca stock, cites valuation gap By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Raymond James Initiates Coverage of Erasca (ERAS) with Outperform Recommendation - Nasdaq

Mar 26, 2025

Mar 26, 2025

This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Mar 26, 2025

Mar 26, 2025

Raymond James sets $5 target for Erasca stock, cites valuation gap - Investing.com India

Mar 26, 2025

Mar 26, 2025

Raymond James Initiates Erasca at Outperform With $5 Price Target - MarketScreener

Mar 26, 2025

Mar 26, 2025

Erasca initiated with an Outperform at Raymond James - TipRanks

Mar 26, 2025

Mar 26, 2025

Charles Schwab Investment Management Inc. Buys 39,066 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 26, 2025

Mar 25, 2025

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting - The Manila Times

Mar 25, 2025

Mar 25, 2025

Game-Changing Cancer Treatments: Erasca Reveals 3 Novel Drug Breakthroughs at AACR 2025 - Stock Titan

Mar 25, 2025

Mar 24, 2025

Bank of New York Mellon Corp Grows Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 24, 2025

Mar 24, 2025

What is HC Wainwright’s Estimate for Erasca FY2029 Earnings? - Defense World

Mar 24, 2025

Mar 23, 2025

The Goldman Sachs Group Has Lowered Expectations for Erasca (NASDAQ:ERAS) Stock Price - Defense World

Mar 23, 2025

Mar 23, 2025

Erasca (NASDAQ:ERAS) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 23, 2025

Mar 21, 2025

Erasca, Inc. Reports 2024 Financial and Strategic Progress - TipRanks

Mar 21, 2025

Mar 20, 2025

Erasca Inc. (ERAS) reports earnings - Quartz

Mar 20, 2025

Mar 20, 2025

ERASCA Earnings Results: $ERAS Reports Quarterly Earnings - Nasdaq

Mar 20, 2025

Mar 20, 2025

Erasca, Inc. SEC 10-K Report - TradingView

Mar 20, 2025

Mar 20, 2025

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results - The Manila Times

Mar 20, 2025

Mar 20, 2025

Erasca's $440M War Chest Powers Two Groundbreaking Cancer Drugs Into 2025 Trials - StockTitan

Mar 20, 2025

Mar 19, 2025

Erasca (ERAS) Expected to Announce Earnings on Wednesday - Defense World

Mar 19, 2025

Mar 10, 2025

Brokerages Set Erasca, Inc. (NASDAQ:ERAS) Price Target at $5.70 - Defense World

Mar 10, 2025

Mar 09, 2025

Morgan Stanley Reaffirms Overweight Rating for Erasca (NASDAQ:ERAS) - Defense World

Mar 09, 2025

Mar 08, 2025

Rhumbline Advisers Boosts Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 08, 2025

Mar 07, 2025

Erasca’s Promising Oncology Advances: Buy Rating Backed by Strong Market Potential and Competitive Edge - TipRanks

Mar 07, 2025

Mar 07, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Acquired by New York State Common Retirement Fund - Defense World

Mar 07, 2025

Feb 28, 2025

Erasca stock hits 52-week low at $1.32 amid market challenges - Investing.com Australia

Feb 28, 2025

Feb 25, 2025

Erasca Inc Still Hasn’t Convinced Analysts? - Stocks Register

Feb 25, 2025

Feb 20, 2025

Erasca stock hits 52-week low at $1.5 amid market challenges - Investing.com Australia

Feb 20, 2025

Feb 19, 2025

Erasca stock hits 52-week low at $1.5 amid market challenges By Investing.com - Investing.com South Africa

Feb 19, 2025

Feb 17, 2025

Metastatic Pancreatic Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Feb 17, 2025

Feb 10, 2025

Investor’s Toolkit: Key Ratios for Assessing Erasca Inc (ERAS)’s Performance - The Dwinnex

Feb 10, 2025

Feb 07, 2025

Erasca Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle

Feb 07, 2025

Feb 07, 2025

Erasca Inc [ERAS] Records 200-Day SMA of $2.5522 - Knox Daily

Feb 07, 2025

Feb 06, 2025

Pyxis Oncology Inc [PYXS] stock for 174,364 USD was acquired by Connealy Pamela Ann - Knox Daily

Feb 06, 2025

Feb 06, 2025

BlackBerry Ltd [BB] Records 200-Day SMA of $2.77 - Knox Daily

Feb 06, 2025

Feb 06, 2025

Erasca (NASDAQ:ERAS) Stock Price Down 6.1%What's Next? - MarketBeat

Feb 06, 2025

Feb 04, 2025

Metric Deep Dive: Understanding Erasca Inc (ERAS) Through its Ratios - The Dwinnex

Feb 04, 2025

Feb 04, 2025

Erasca Inc (ERAS) is a good investment, but the stock may be undervalued - US Post News

Feb 04, 2025

Feb 03, 2025

Erasca (NASDAQ:ERAS) Trading Up 6.6%Time to Buy? - MarketBeat

Feb 03, 2025

Jan 31, 2025

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference - The Manila Times

Jan 31, 2025

Jan 31, 2025

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire Inc.

Jan 31, 2025

Jan 28, 2025

Erasca: Future 'Streamlined' But Still Uncertain (NASDAQ:ERAS) - Seeking Alpha

Jan 28, 2025

Jan 27, 2025

What Are You Thinking About Investing In Erasca Inc (NASDAQ: ERAS) Stock? - Stocks Register

Jan 27, 2025

Jan 27, 2025

Erasca’s Naporafenib Is Shaping Up Nicely For NRASm Melanoma (NASDAQ:ERAS) - Seeking Alpha

Jan 27, 2025

Jan 22, 2025

Down -25.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS) - MSN

Jan 22, 2025